The immunosuppressive ligands PD-L1 and CD200 are linked in AML T-cell immunosuppression: identification of a new immunotherapeutic synapse

被引：50

作者：

Coles, S. J. ^{[1
,2
]}

Gilmour, M. N. ^{[2
]}

Reid, R. ^{[2
]}

Knapper, S. ^{[2
]}

Burnett, A. K. ^{[2
]}

Man, S. ^{[2
]}

Tonks, A. ^{[2
]}

Darley, R. L. ^{[2
]}

机构：

[1] Univ Worcester, Inst Sci & Environm, Worcester, England

[2] Cardiff Univ, Inst Canc & Genet, Dept Haematol, Sch Med, Cardiff CF10 3AX, S Glam, Wales

来源：

LEUKEMIA | 2015年 / 29卷 / 09期

基金：

英国医学研究理事会;

关键词：

ACUTE MYELOID-LEUKEMIA; EXPRESSION; LYMPHOCYTES; BLOCKADE;

D O I：

10.1038/leu.2015.62

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：1952 / 1954

页数：3

共 18 条

[1]

The stimulation of PD-L1-specific cytotoxic T lymphocytes can both directly and indirectly enhance antileukemic immunity [J].

Ahmad, S. M. ;

Svane, I. M. ;

Andersen, M. M. .

BLOOD CANCER JOURNAL, 2014, 4 :e230-e230

[2]

Functional Unresponsiveness and Replicative Senescence of Myeloid Leukemia Antigen-specific CD8+ T Cells After Allogeneic Stem Cell Transplantation [J].

Beatty, Gregory L. ;

Smith, Jasmine S. ;

Reshef, Ran ;

Patel, Kunal P. ;

Colligon, Theresa A. ;

Vance, Barbara A. ;

Frey, Noelle V. ;

Johnson, F. Brad ;

Porter, David L. ;

Vonderheide, Robert H. .

CLINICAL CANCER RESEARCH, 2009, 15 (15) :4944-4953

[3]

In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors [J].

Berthon, Celine ;

Driss, Virginie ;

Liu, Jizhong ;

Kuranda, Klaudia ;

Leleu, Xavier ;

Jouy, Nathalie ;

Hetuin, Dominique ;

Quesnel, Bruno .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (12) :1839-1849

[4]

Increased CD200 expression in acute myeloid leukemia is linked with an increased frequency of FoxP3+ regulatory T cells [J].

Coles, S. J. ;

Hills, R. K. ;

Wang, E. C. Y. ;

Burnett, A. K. ;

Man, S. ;

Darley, R. L. ;

Tonks, A. .

LEUKEMIA, 2012, 26 (09) :2146-2148

[5]

Expression of CD200 on AML blasts directly suppresses memory T-cell function [J].

Coles, S. J. ;

Hills, R. K. ;

Wang, E. C. Y. ;

Burnett, A. K. ;

Man, S. ;

Darley, R. L. ;

Tonks, A. .

LEUKEMIA, 2012, 26 (09) :2148-2151

[6]

CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia [J].

Coles, S. J. ;

Wang, E. C. Y. ;

Man, S. ;

Hills, R. K. ;

Burnett, A. K. ;

Tonks, A. ;

Darley, R. L. .

LEUKEMIA, 2011, 25 (05) :792-799

[7]

Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors [J].

Duraiswamy, Jaikumar ;

Kaluza, Karen M. ;

Freeman, Gordon J. ;

Coukos, George .

CANCER RESEARCH, 2013, 73 (12) :3591-3603

[8]

Blockade of CD200 in the presence or absence of antibody effector function: Implications for anti-CD200 therapy [J].

Kretz-Ronlmel, Anke ;

Qin, Fenghua ;

Dakappagari, Naveen ;

Cofiell, Roxanne ;

Faas, Susan J. ;

Bowdish, Katherine S. .

JOURNAL OF IMMUNOLOGY, 2008, 180 (02) :699-705

[9]

Clinical evaluation of compounds targeting PD-1/PD-L1 pathway for cancer immunotherapy [J].

Lu, Jing ;

Lee-Gabel, Linda ;

Nadeau, Michelle C. ;

Ferencz, Thomas M. ;

Soefje, Scott A. .

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2015, 21 (06) :451-467

[10]

Coinhibitory molecules in hematologic malignancies: targets for therapeutic intervention [J].

Norde, Wieger J. ;

Hobo, Willemijn ;

van der Voort, Robbert ;

Dolstra, Harry .

BLOOD, 2012, 120 (04) :728-736

← 1 2 →